期刊文献+

Resistant prolactinoma:Is it monoclonal or polyclonal?

Resistant prolactinoma:Is it monoclonal or polyclonal?
下载PDF
导出
摘要 Prolactinomas are solitary benign neoplasms and resistance to dopamine agonists occur in a small percentage of prolactinomas.Multiple pituitary adenomas are reported in less than 1%of pituitary adenomas and rarely result in resistant prolactinoma.We recently encountered an interesting patient of hyperprolactinemia with multiple pituitary microadenomas.Dopamine agonist use resulted in prolactin normalization and subsequent pregnancy resulted in drug withdrawal.Repeat evaluation after delivery showed Prolactinomas are solitary benign neoplasms and resistance to dopamine agonists occur in a small percentage of prolactinomas. Multiple pituitary adenomas are reported in less than 1% of pituitary adenomas and rarely result in resistant prolactinoma. We recently encountered an interesting patient of hyperprolactinemia with multiple pituitary microadenomas. Dopamine agonist use resulted in prolactin normalization and subsequent pregnancy resulted in drug withdrawal. Repeat evaluation after delivery showed a macroprolactinoma and dopamine agonist therapy resulted in biochemical cure without reduction in tumor size. We report the case for its presentation with multiple microadenomas progressing to macroprolactinoma suggesting polyclonal in origin.
出处 《中国神经肿瘤杂志》 2013年第4期241-241,共1页 Chinese Journal of Neuro-Oncology
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部